medEasy MedEasy
Product gallery

Beviprex(9 mcg+4.8 mcg)/puff

Inhaler

Glycopyrronium Bromide + Formoterol Fumarate
BySquare Pharmaceuticals PLC.
MRP ৳ 450.0010 % Off
Best PriceTk 405.00/120 metered doses
1
Section

Medicine overview

Indications of Beviprex (9 mcg+4.8 mcg)/puff

It is indicated for the maintenance treatment of patients with chronic obstructive pulmonary disease (COPD), including chronic bronchitis and/or emphysema.

Composition

Each puff delivers- Through the actuator: Glycopyrronium Bromide EP 9 mcg and Formoterol Fumarate EP 4.8 mcg & Through the valve: Glycopyrronium Bromide EP 10.35 mcg and Formoterol Fumarate EP 5.52 mcg.

Dosage of Beviprex (9 mcg+4.8 mcg)/puff

Adults: Should be administered as 2 puffs twice daily, in the morning and in the evening.Use in patients with severe renal impairment should be considered if the potential benefit of the treatment outweighs the risk.

Interaction of Beviprex (9 mcg+4.8 mcg)/puff

Other adrenergic drugs may potentiate efect. Use with caution. Xanthine derivatives, steroids, diuretics or non-potassium sparing diuretics may potentiate hypokalemia or EDG changes. Use with caution. Diuretics: Use with caution. Monoamine oxidase inhibitors and tricyclic antidepressants: Use with extreme caution. May potentiate efect of formoterol fumarate on cardiovascular system. Beta-Blockers: Use with caution and only when medically necessary. Anticholinergics: May interact additively with concomitantly used anticholinergic medications. Avoid administrations of this combination with other anticholinergic-containing drugs.

Contraindications

All LABAs are contraindicated in patients with asthma without use of a long-term asthma control medication. This preparation is also contraindicated in patients with hypersensitivity to glycopyrronium bromide, formoterol fumarate or to any component of the product.

Side Effects of Beviprex (9 mcg+4.8 mcg)/puff

The most common adverse reactions include cough and urinary tract infection. Possible side efects are sudden breathing problems, headache, tremor, nervousness, rash, swelling of the face, mouth and tongue, hives, increase blood pressure, chest pain, irregular heartbeat, muscle spasm, muscle weakness, eye pain or discomfort and urinary retention.

Precautions & Warnings

This combination should not be used with an additional medicine containing a LABA because of risk of overdose. Not indicated for the relief of acute bronchospasm Do not initiate in acutely deteriorating COPD or to treat acute symptoms If paradoxical bronchospasm occurs, discontinue this combination and institute alternative therapy Use with caution in patients with cardiovascular disorders Use with patients with convulsive disorders, thyrotoxicosis, diabetes mellitus and ketoacidosis. Be alert to hypokalemia and hyperglycemia Worsening of narrow angle glaucoma may occur. Use with caution with patients with narrow-angle glaucoma Worsening of urinary retention may occur. Use with caution with patients with prostatic hyperplasia or bladder-neck obstruction

Storage Conditions

Do not store above 30°C. Do not expose to temperatures higher than 50°C. Do not pierce the pressurized container. Keep out of the reach of the children.

Mode Of Action

This preparation contains two bronchodilators: Glycopyrronium is a long-acting muscarinic antagonist (LAMA) and Formoterol is a long-acting β2-adrenergic agonist (LABA) with a rapid onset of action. Glycopyrronium has similar afnity to the subtypes of muscarinic receptors M1 to M5. In the airways, it exhibits pharmacological efects through inhibition of the M3 receptor at the smooth muscle leading to bronchodilation. Formoterol causes direct relaxation of airway smooth muscle as a consequence of the increase in cyclic AMP through activation of adenylyl cyclase.

Pregnancy

There are no data on the use of this preparation in pregnant women.

Frequently Asked Questions

What is Beviprex (9 mcg+4.8 mcg)/puff used for?

It is indicated for the maintenance treatment of patients with chronic obstructive pulmonary disease (COPD), including chronic bronchitis and/or emphysema.

What is the dosage of Beviprex (9 mcg+4.8 mcg)/puff?

Adults: Should be administered as 2 puffs twice daily, in the morning and in the evening.Use in patients with severe renal impairment should be considered if the potential benefit of the treatment outweighs the risk.

What are the side effects of Beviprex (9 mcg+4.8 mcg)/puff?

The most common adverse reactions include cough and urinary tract infection. Possible side efects are sudden breathing problems, headache, tremor, nervousness, rash, swelling of the face, mouth and tongue, hives, increase blood pressure, chest pain, irregular heartbeat, muscle spasm, muscle weakness, eye pain or discomfort and urinary retention.

Who should not take Beviprex (9 mcg+4.8 mcg)/puff?

All LABAs are contraindicated in patients with asthma without use of a long-term asthma control medication. This preparation is also contraindicated in patients with hypersensitivity to glycopyrronium bromide, formoterol fumarate or to any component of the product.

What precautions should be taken with Beviprex (9 mcg+4.8 mcg)/puff?

This combination should not be used with an additional medicine containing a LABA because of risk of overdose. Not indicated for the relief of acute bronchospasm Do not initiate in acutely deteriorating COPD or to treat acute symptoms If paradoxical bronchospasm occurs, discontinue this combination and institute alternative therapy Use with caution in patients with cardiovascular disorders Use wit…

Disclaimer

The information provided is accurate to our best practices, but it does not replace professional medical advice. We cannot guarantee its completeness or accuracy. The absence of specific information about a drug should not be seen as an endorsement. We are not responsible for any consequences resulting from this information, so consult a healthcare professional for any concerns or questions.

Home